Original Research
Published on 06 Feb 2023
Transitioning from epicutaneous to oral peanut immunotherapy
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2023.1089308
- 2,335 views
- 6 citations
Type at least 3 characters
29 articles
Original Research
Published on 10 Jan 2023
Cationic liposomes bearing Bet v 1 by coiled coil-formation are hypo-allergenic and induce strong immunogenicity in mice
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2022.1092262
- 2,912 views
- 2 citations
Original Research
Published on 17 Nov 2022
Immunogenicity of a novel anti-allergic vaccine based on house dust mite purified allergens and a combination adjuvant in a murine prophylactic model
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2022.1040076
- 2,943 views
- 3 citations
Original Research
Published on 11 Oct 2022
Manufacturing processes of peanut (Arachis hypogaea) allergen powder-dnfp
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2022.1004056
- 4,604 views
- 9 citations
Original Research
Published on 09 Aug 2022
The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2022.971155
- 3,765 views
- 10 citations
Review
Published on 03 Aug 2022
Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2022.981126
- 4,724 views
- 18 citations
Mini Review
Published on 12 Jul 2022
Measuring the Impact of Food Immunotherapy on Health-Related Quality of Life in Clinical Trials
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2022.941020
- 4,599 views
- 10 citations
Review
Published on 28 Jun 2022
Patient's Adherence and Compliance and Quality of Life During/After VIT
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2022.886054
- 4,259 views
- 1 citation
Mini Review
Published on 16 Jun 2022
Mast Cell Desensitization in Allergen Immunotherapy
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2022.898494
- 10,174 views
- 7 citations
Clinical Trial
Published on 16 Mar 2022
Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2022.832010
- 4,915 views
- 10 citations
Original Research
Published on 05 Jan 2022
Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2021.810133
- 4,810 views
- 4 citations
Brief Research Report
Published on 16 Dec 2021
Specific Immunotherapy in a Murine Model of Grass Pollen (Phl p5b)-Induced Airway Inflammation
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2021.777545
- 2,285 views
- 2 citations
Specialty Grand Challenge
Published on 05 Aug 2021
Grand Challenges in Allergen Immunotherapy
in Allergen Immunotherapy
Frontiers in Allergy
doi 10.3389/falgy.2021.710345
- 3,539 views
- 2 citations